This is the current revision of this page, as edited by Marbletan (talk | contribs) at 16:34, 5 December 2024 (Bibrocathol structure a.svg). The present address (URL) is a permanent link to this version.
Revision as of 16:34, 5 December 2024 by Marbletan (talk | contribs) (Bibrocathol structure a.svg)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) Chemical compound Pharmaceutical compoundClinical data | |
---|---|
Trade names | Noviform, Posiformin |
Other names | Bibrocathin Tetrabromopyrocatechol bismuth |
AHFS/Drugs.com | International Drug Names |
Routes of administration | Topical (eye ointment) |
ATC code | |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.027.294 |
Chemical and physical data | |
Formula | C6HBiBr4O3 |
Molar mass | 649.667 g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(what is this?) (verify) |
Bibrocathol (INN; trade names Noviform and Posiformin) is a pharmaceutical antiseptic. Its chemical name is 4,5,6,7-tetrabrom-1,3,2-benzodioxabismol-2-ol. It contains bismuth and is used to treat eye infections and control swelling.
References
- Gurtler L (January 2002). "Chapter 2: The Eye and Conjunctiva as Target of Entry for Infectious Agents: Prevention by Protection and by Antiseptic Prophylaxis". In Kramer A, Behrens-Baumann W (eds.). Antiseptic prophylaxis and therapy in ocular infections: principles, clinical practice, and infection control. Developments in Ophthalmology. Vol. 33. Basel: Karger. pp. 9–13. doi:10.1159/000065934. ISBN 978-3-8055-7316-0. PMID 12236131.
External links
- Media related to Bibrocathol at Wikimedia Commons
Bismuth compounds | |||
---|---|---|---|
Bismuth(III) |
| ||
Bismuth(V) |
|
This antiinfective drug article is a stub. You can help Misplaced Pages by expanding it. |